Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia? (Q48149239)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia? |
scientific article |
Statements
Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia? (English)
Johannes Rieger
Oliver Bähr
Joachim Steinbach
e477; author reply e478